Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Stealth Biotherapeutics Corp Ads (MITO)

Stealth Biotherapeutics Corp Ads (MITO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Stealth Biotherapeutics Corp Ads 275 GROVE STREET SUITE 3-107 NEWTON MA 02466 USA

P: 617-600-6888

Description:

Stealth BioTherapeutics Corp is a biopharmaceutical company. It is engaged in developing therapies to treat the mitochondrial dysfunction associated with genetic mitochondrial diseases and many common age-related diseases. The company's product pipeline includes Elamipretide, SBT-20 and SBT-272 which are in clinical stage. Stealth BioTherapeutics Corp is based in Newton, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 46,240
Shares Outstanding, K 35,030
Annual Sales, $ 21,090 K
Annual Net Income, $ -71,730 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -15,540 K
60-Month Beta 2.47
% of Institutional Shareholders 2.39%
Float, K 35,030
% Float 100.00%

Growth:

1-Year Return -74.14%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/12/20
Earnings Per Share ttm 0.00
EPS Growth vs. Prev Qtr 50.00%
EPS Growth vs. Prev Year 50.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

MITO Ratios

Ratio
Price/Earnings ttm 67.50
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -465.59%
Return-on-Assets % -102.96%
Profit Margin % -340.11
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 2.24
Price/Cash Flow N/A
Price/Book 4.08
Book Value/Share 0.07
Interest Coverage -9.75
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar